Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 200.00% to -5 cents per share on November 16

Protalix BioTherapeutics PLX Stock Earnings Reports

Q3'26

Est.

$-0.05

Q2'26

Missed

by $0.07

Q1'26

Beat

by $0.18

Q4'25

Missed

by $0.11

Q3'25

Missed

by $0.04

The last earnings report on August 12 showed earnings per share of 5 cents, missing the estimate of 11 cents. With 434.49K shares outstanding, the current market capitalization sits at 216.74M.

View a ticker or compare two or three

PLX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PLX